RxDoctor Payments Data

Louis Pilati, MD

Undersea and Hyperbaric Medicine · Miamisburg, OHNPI 1205886439

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $33,100 of the $45,653 with a category attached, or 72.5%. Urgo Medical North America, LLC accounts for 94.9% of it on its own, with 7 other manufacturers making up the rest. Reporting peaked in 2022 at $16,615 and has fallen 89.1% since, to $1,819 in 2025.

$45,653in general payments, 2019–2025

Across 42 payments — averaging $1086.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Urgo Medical North America, LLC$43K
  • Integra Lifesciences Corporation$2K
  • Medline Industries LP$149
  • KCI USA, Inc.$116
  • Smith+Nephew$106
  • Molnlycke Health Care US, LLC$98
  • plus $70 from 2 others
$43,988in research payments, 2019–2025

Across 3 payments — averaging $14,663 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Molnlycke Health Care AB$44K

What the payments were for

  • Consulting fees$10,00022%
  • Speaking & faculty fees$33,10073%
  • Food & beverage$8782%
  • Education$120%
  • Other$1,6634%

General payments by program year

19
20
21
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

Too few undersea and hyperbaric medicine providers in Ohioto place this figure against a meaningful peer group, so we don't.

Medicare billing

Part B allowed, 2024
$187,885
Medicare patients
391
Services billed
2,354

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
SsdSilver Sulfadiazine32$708
Silver Sulfadiazine35$623
Doxycycline Monohydrate31$493
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav25$212
Cephalexin16$87

Paid to pharmacies, not to this prescriber.

Other undersea and hyperbaric medicine in Miamisburg

Where these figures come from

Is this you, or does something look wrong? →